Clinical Trial Update: Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A two-part Phase 1/2 clinical trial evaluating the combination of Nenocorilant with nivolumab in patients with advanced solid malignancies is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Nenocorilant (nenocorilant)
• nivolumab (nivolumab)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Neoplasms | Phase 1, Phase 2 | Status: RECRUITING